23rd and 24th June, 2022

3rd Annual MarketsandMarkets Single-Cell Analysis Conference

Boston, USA

Single-cell sequencing (SCS) is new effective tool for investigating the evolution and variety of most cancers and role of circulating tumor cells in cancer progression. These methods have started to unravel key questions in cancer biology which have been hard to deal with for bulk tumor measurements. Over the span of 5 years, there has been exceptional development in technology and applications of Single-cell analysis.

Recent advances in single cell technologies have opened new avenues to signify the intra-tumor cell heterogeneity, identify rare cell kinds, degree of mutation, and, ultimately guide diagnosis and treatment option.

Our MarketsandMarkets Virtual conference on Single-Cell analysis scheduled to be held on 23rd and 24th June, 2022, Boston,  aims to bring together the Researchers, Scientists from top universities and Pharmaceutical companies from all around the globe to address the recent developments and challenges in analyzing single cell and also provides the platform to share the knowledge with academic peers and present their research papers and reports.

Key Highlights
  • The growth of Single-Cell analysis in recent years
  • Address the challenges faced to isolate Single-Cell
  • Single-Cell and microfluidics
  • Advancement in technology to detect metastatic cancer
  • Progression of single-cell sequencing in cancer genomics
  • Future opportunities with Single-Cell analysis
Why Attend?
  • Learn about the Single- Cell Biology and its applications
  • Meet global leaders and researchers from the industry and Academics
  • 100+ Professional attending from all around the globe
  • Access to online presentations on-demand post-summit
  • Case studies presented from leading technology collaborations 
  • Interactive panel discussions
  • Futuristic Agenda
  • Program address the recent challenges in the field of research
Boston, USA
About the Hotel